Literature DB >> 3791621

Do hypertension and aging have a similar effect on the myocardium?

E G Lakatta.   

Abstract

Vascular stiffening and a modest increase in cardiac mass with advancing age in man resemble similar alterations accompanying chronic arterial hypertension. In both hypertensive and elderly normotensive individuals, systolic pump function at rest is not altered, while early filling rate and volume are decreased. Although this abnormality is often attributed to the cardiac hypertrophy per se, prolonged isometric relaxation, which occurs with aging in man and animals and in some types of experimental hypertension, is an equally plausible mechanism. In the aged rat, prolonged relaxation can be attributed to a prolonged myoplasmic Ca++ transient with excitation. This occurs amidst a constellation of other cellular changes, among which are a markedly prolonged transmembrane action potential, diminished sarcoplasmic reticulum Ca++ pumping rate, and altered myosin isozyme composition. Many of these changes occur in cardiac muscle of younger animals with cardiac hypertrophy due to chronic increased afterload. While the magnitude of these alterations with advanced age is as great as those with chronic hypertension in younger animals, the magnitude of left ventricular hypertrophy with aging is far less than that in experimental hypertension. Furthermore, with aging, these alterations occur not only in the myocardium of the left but also of the right heart (which does not hypertrophy). Thus, myocardial hypertrophy per se does not appear to be the common link between cellular changes due to aging and those due to hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3791621

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve?

Authors:  N Doba; H Tomiyama; T Nakayama
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

Review 2.  Ageing and its effects on the cardiovascular system.

Authors:  M Safar
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Intracardiac expression of neutral endopeptidase.

Authors:  V Raizada; W Luo; B J Skipper; P G McGuire
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

4.  Beneficial cardiac effects of caloric restriction are lost with age in a murine model of obesity.

Authors:  Majd AlGhatrif; Vabren L Watts; Xiaolin Niu; Marc Halushka; Karen L Miller; Konrad Vandegaer; Djahida Bedja; Karen Fox-Talbot; Alicja Bielawska; Kathleen L Gabrielson; Lili A Barouch
Journal:  J Cardiovasc Transl Res       Date:  2013-03-02       Impact factor: 4.132

5.  Age and hypertrophy related changes in contractile post-rest behavior and action potential properties in isolated rat myocytes.

Authors:  Jutta Weisser-Thomas; Quan Nguyen; Manuela Schuettel; Daniel Thomas; Ulrike Dreiner; Christian Grohé; Rainer Meyer
Journal:  Age (Dordr)       Date:  2007-09-30

6.  Postural blood pressure changes and associated factors in long-term Type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  Flavio E Hirai; Scot E Moss; Barbara E K Klein; Ronald Klein
Journal:  J Diabetes Complications       Date:  2008-04-16       Impact factor: 2.852

Review 7.  Is the senescent heart overloaded and already failing?

Authors:  S Besse; C Delcayre; B Chevalier; S Hardouin; C Heymes; F Bourgeois; J M Moalic; B Swynghedauw
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 8.  Hypertension in the elderly: age- and disease-related complications and therapeutic implications.

Authors:  E G Lakatta; J D Cohen; J L Fleg; E D Frohlich; A H Gradman
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.